▶ 調査レポート

高効能医薬品有効成分(API)のグローバル市場

• 英文タイトル:Global Market Study on High Potency Active Pharmaceutical Ingredients: Surge in oncology treatments to catalyze the demand in the forthcoming years

Global Market Study on High Potency Active Pharmaceutical Ingredients: Surge in oncology treatments to catalyze the demand in the forthcoming years「高効能医薬品有効成分(API)のグローバル市場」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2304I0173
• 出版社/出版日:Persistence Market Research / 2023年1月31日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Site Licence¥1,140,000 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,590,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、世界の高効能医薬品有効成分(API)市場にフォーカスし、最新動向と今後の市場性について分析しています。本書は、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景、主要成功要因、需要分析・予測、価値分析、製品別(合成、バイオ)分析、製造業者別(インハウス、アウトソーシング)分析、医薬品別(革新的、ジェネリック)分析、用途別(腫瘍、ホルモンの乱れ、緑内障、その他)分析、地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ)分析、市場構造分析、競争分析、仮定、調査手法などの情報を整理しています。また、BASF SE、CordenPharma、Dr. Reddy’s Laboratories Ltd.、CARBOGEN AMCIS AG、Pfizer, Inc.、Sun Pharmaceutical Industries, Ltd.、Teva Pharmaceutical Industries Ltd.、Albany Molecular Research, Inc.、Sanofi S.A.、Merck & Co., Inc.、Novartis AG、F. Hoffmann-La Roche Ltd.、Bristol-Myers Squibb Company、Boehringer Ingelheim International GmbH、Cipla Inc.など、主要企業情報が含まれています。

・エグゼクティブサマリー
・市場概要
・市場リスク・動向分析
・市場背景
・主要成功要因
・需要分析・予測
・価値分析
・世界の高効能医薬品有効成分(API)市場規模:製品別
- 合成高性能医薬品有効成分の市場規模
- バイオ高性能医薬品有効成分の市場規模
・世界の高効能医薬品有効成分(API)市場規模:製造業者別
- インハウスにおける市場規模
- アウトソーシングにおける市場規模
・世界の高効能医薬品有効成分(API)市場規模:医薬品別
- 革新的高性能医薬品有効成分の市場規模
- ジェネリック高性能医薬品有効成分の市場規模
・世界の高効能医薬品有効成分(API)市場規模:用途別
- 腫瘍における市場規模
- ホルモンの乱れにおける市場規模
- 緑内障における市場規模
- その他用途における市場規模
・世界の高効能医薬品有効成分(API)市場規模:地域別
- 北米の高効能医薬品有効成分(API)市場規模
- 中南米の高効能医薬品有効成分(API)市場規模
- ヨーロッパの高効能医薬品有効成分(API)市場規模
- アジア太平洋の高効能医薬品有効成分(API)市場規模
- 中東・アフリカの高効能医薬品有効成分(API)市場規模
・市場構造分析
・競争分析
・仮定
・調査手法

High Potency Active Pharmaceutical Ingredients Market- Scope of Report

A recent study by Persistence Market Research on the High Potency Active Pharmaceutical Ingredients market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering High Potency Active Pharmaceutical Ingredients.

The study also provides the dynamics responsible for influencing the future status of the High Potency Active Pharmaceutical Ingredients market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the High Potency Active Pharmaceutical Ingredients market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of High Potency Active Pharmaceutical Ingredients across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of High Potency Active Pharmaceutical Ingredients during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for High Potency Active Pharmaceutical Ingredients and the High Potency Active Pharmaceutical Ingredients market are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global High Potency Active Pharmaceutical Ingredients Market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the High Potency Active Pharmaceutical Ingredients market during the forecast period.

Country-specific valuation on demand for High Potency Active Pharmaceutical Ingredients has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading players of High Potency Active Pharmaceutical Ingredients market along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering High Potency Active Pharmaceutical Ingredients has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the High Potency Active Pharmaceutical Ingredients domain.

レポート目次

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage

    2.2. Market Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on High Potency Active Pharmaceutical Ingredients

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. High Potency Active Pharmaceutical Ingredients Market, by Key Countries

    4.2. High Potency Active Pharmaceutical Ingredients Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors – Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. High Potency Active Pharmaceutical Ingredients Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. High Potency Active Pharmaceutical Ingredients Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global High Potency Active Pharmaceutical Ingredients Market Demand Analysis 2018-2022 and Forecast, 2023-2033

    6.1. Historical Market Analysis, 2018-2022

    6.2. Current and Future Market Projections, 2023-2033

    6.3. Y-o-Y Growth Trend Analysis

7. Global High Potency Active Pharmaceutical Ingredients Market Value Analysis 2018-2022 and Forecast, 2023-2033

    7.1. Historical Market Value (US$ Mn) Analysis, 2018-2022

    7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033, By Product Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2018-2022

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2023-2033

        8.3.1. Synthetic

        8.3.2. Biotech

    8.4. Market Attractiveness Analysis By Product Type

9. Global High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033, By Manufacturer Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Manufacturer Type, 2018-2022

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Manufacturer Type, 2023-2033

        9.3.1. In-house

        9.3.2. Outsourced

    9.4. Market Attractiveness Analysis By Manufacturer Type

10. Global High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2018-2022

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2023-2033

        10.3.1. Innovative

        10.3.2. Generic

    10.4. Market Attractiveness Analysis By Drug Type

11. Global High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033, By Application

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Application, 2018-2022

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2023-2033

        11.3.1. Oncology

        11.3.2. Hormonal Disorders

        11.3.3. Glaucoma

        11.3.4. Other Applications

    11.4. Market Attractiveness Analysis By Application

12. Global High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2022

    12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2023-2033

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Asia Pacific

        12.3.5. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033

        13.4.1. By Country

            13.4.1.1. U.S.

            13.4.1.2. Canada

            13.4.1.3. Rest of North America

        13.4.2. By Product Type

        13.4.3. By Manufacturer Type

        13.4.4. By Application

        13.4.5. By Drug Type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product Type

        13.5.3. By Manufacturer Type

        13.5.4. By Application

        13.5.5. By Drug Type

14. Latin America High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033

        14.4.1. By Country

            14.4.1.1. Brazil

            14.4.1.2. Mexico

            14.4.1.3. Rest of Latin America

        14.4.2. By Product Type

        14.4.3. By Manufacturer Type

        14.4.4. By Application

        14.4.5. By Drug Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product Type

        14.5.3. By Manufacturer Type

        14.5.4. By Application

        14.5.5. By Drug Type

15. Europe High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033

        15.4.1. By Country

            15.4.1.1. Germany

            15.4.1.2. France

            15.4.1.3. U.K.

            15.4.1.4. Italy

            15.4.1.5. Benelux

            15.4.1.6. Nordic Countries

            15.4.1.7. Rest of Europe

        15.4.2. By Product Type

        15.4.3. By Manufacturer Type

        15.4.4. By Application

        15.4.5. By Drug Type

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product Type

        15.5.3. By Manufacturer Type

        15.5.4. By Application

        15.5.5. By Drug Type

16. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033

        16.4.1. By Country

            16.4.1.1. China

            16.4.1.2. Japan

            16.4.1.3. South Korea

            16.4.1.4. Rest of Asia Pacific

        16.4.2. By Product Type

        16.4.3. By Manufacturer Type

        16.4.4. By Application

        16.4.5. By Drug Type

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product Type

        16.5.3. By Manufacturer Type

        16.5.4. By Application

        16.5.5. By Drug Type

17. Middle East and Africa High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033

        17.4.1. By Country

            17.4.1.1. GCC Countries

            17.4.1.2. South Africa

            17.4.1.3. Turkey

            17.4.1.4. Rest of Middle East and Africa

        17.4.2. By Product Type

        17.4.3. By Manufacturer Type

        17.4.4. By Application

        17.4.5. By Drug Type

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product Type

        17.5.3. By Manufacturer Type

        17.5.4. By Application

        17.5.5. By Drug Type

18. Key Countries High Potency Active Pharmaceutical Ingredients Market Analysis 2018-2022 and Forecast 2023-2033

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. US High Potency Active Pharmaceutical Ingredients Market Analysis

        18.2.1. Value Proportion Analysis by Market Taxonomy

        18.2.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.2.2.1. By Product Type

            18.2.2.2. By Manufacturer Type

            18.2.2.3. By Application

            18.2.2.4. By Drug Type

    18.3. Canada High Potency Active Pharmaceutical Ingredients Market Analysis

        18.3.1. Value Proportion Analysis by Market Taxonomy

        18.3.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.3.2.1. By Product Type

            18.3.2.2. By Manufacturer Type

            18.3.2.3. By Application

            18.3.2.4. By Drug Type

    18.4. Mexico High Potency Active Pharmaceutical Ingredients Market Analysis

        18.4.1. Value Proportion Analysis by Market Taxonomy

        18.4.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.4.2.1. By Product Type

            18.4.2.2. By Manufacturer Type

            18.4.2.3. By Application

            18.4.2.4. By Drug Type

    18.5. Brazil High Potency Active Pharmaceutical Ingredients Market Analysis

        18.5.1. Value Proportion Analysis by Market Taxonomy

        18.5.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.5.2.1. By Product Type

            18.5.2.2. By Manufacturer Type

            18.5.2.3. By Application

            18.5.2.4. By Drug Type

    18.6. Germany High Potency Active Pharmaceutical Ingredients Market Analysis

        18.6.1. Value Proportion Analysis by Market Taxonomy

        18.6.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.6.2.1. By Product Type

            18.6.2.2. By Manufacturer Type

            18.6.2.3. By Application

            18.6.2.4. By Drug Type

    18.7. France High Potency Active Pharmaceutical Ingredients Market Analysis

        18.7.1. Value Proportion Analysis by Market Taxonomy

        18.7.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.7.2.1. By Product Type

            18.7.2.2. By Manufacturer Type

            18.7.2.3. By Application

            18.7.2.4. By Drug Type

    18.8. Italy High Potency Active Pharmaceutical Ingredients Market Analysis

        18.8.1. Value Proportion Analysis by Market Taxonomy

        18.8.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.8.2.1. By Product Type

            18.8.2.2. By Manufacturer Type

            18.8.2.3. By Application

            18.8.2.4. By Drug Type

    18.9. BENELUX High Potency Active Pharmaceutical Ingredients Market Analysis

        18.9.1. Value Proportion Analysis by Market Taxonomy

        18.9.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.9.2.1. By Product Type

            18.9.2.2. By Manufacturer Type

            18.9.2.3. By Application

            18.9.2.4. By Drug Type

    18.10. UK High Potency Active Pharmaceutical Ingredients Market Analysis

        18.10.1. Value Proportion Analysis by Market Taxonomy

        18.10.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.10.2.1. By Product Type

            18.10.2.2. By Manufacturer Type

            18.10.2.3. By Application

            18.10.2.4. By Drug Type

    18.11. Nordic Countries High Potency Active Pharmaceutical Ingredients Market Analysis

        18.11.1. Value Proportion Analysis by Market Taxonomy

        18.11.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.11.2.1. By Product Type

            18.11.2.2. By Manufacturer Type

            18.11.2.3. By Application

            18.11.2.4. By Drug Type

    18.12. China High Potency Active Pharmaceutical Ingredients Market Analysis

        18.12.1. Value Proportion Analysis by Market Taxonomy

        18.12.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.12.2.1. By Product Type

            18.12.2.2. By Manufacturer Type

            18.12.2.3. By Application

            18.12.2.4. By Drug Type

    18.13. Japan High Potency Active Pharmaceutical Ingredients Market Analysis

        18.13.1. Value Proportion Analysis by Market Taxonomy

        18.13.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.13.2.1. By Product Type

            18.13.2.2. By Manufacturer Type

            18.13.2.3. By Application

            18.13.2.4. By Drug Type

    18.14. South Korea High Potency Active Pharmaceutical Ingredients Market Analysis

        18.14.1. Value Proportion Analysis by Market Taxonomy

        18.14.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.14.2.1. By Product Type

            18.14.2.2. By Manufacturer Type

            18.14.2.3. By Application

            18.14.2.4. By Drug Type

    18.15. GCC Countries High Potency Active Pharmaceutical Ingredients Market Analysis

        18.15.1. Value Proportion Analysis by Market Taxonomy

        18.15.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.15.2.1. By Product Type

            18.15.2.2. By Manufacturer Type

            18.15.2.3. By Application

            18.15.2.4. By Drug Type

    18.16. South Africa High Potency Active Pharmaceutical Ingredients Market Analysis

        18.16.1. Value Proportion Analysis by Market Taxonomy

        18.16.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.16.2.1. By Product Type

            18.16.2.2. By Manufacturer Type

            18.16.2.3. By Application

            18.16.2.4. By Drug Type

    18.17. Turkey High Potency Active Pharmaceutical Ingredients Market Analysis

        18.17.1. Value Proportion Analysis by Market Taxonomy

        18.17.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033

            18.17.2.1. By Product Type

            18.17.2.2. By Manufacturer Type

            18.17.2.3. By Application

            18.17.2.4. By Drug Type

        18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Product footprint by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. BASF SE

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Strategy Overview

        20.3.2. CordenPharma

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Strategy Overview

        20.3.3. Dr. Reddy’s Laboratories Ltd.

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Strategy Overview

        20.3.4. CARBOGEN AMCIS AG

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Strategy Overview

        20.3.5. Pfizer, Inc.

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Strategy Overview

        20.3.6. Sun Pharmaceutical Industries, Ltd.

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Strategy Overview

        20.3.7. Teva Pharmaceutical Industries Ltd.

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Sales Footprint

            20.3.7.4. Strategy Overview

        20.3.8. Albany Molecular Research, Inc.

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Sales Footprint

            20.3.8.4. Strategy Overview

        20.3.9. Sanofi S.A.

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Sales Footprint

            20.3.9.4. Strategy Overview

        20.3.10. Merck & Co., Inc.

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Sales Footprint

            20.3.10.4. Strategy Overview

        20.3.11. Novartis AG

            20.3.11.1. Overview

            20.3.11.2. Product Portfolio

            20.3.11.3. Sales Footprint

            20.3.11.4. Strategy Overview

        20.3.12. F. Hoffmann-La Roche Ltd.

            20.3.12.1. Overview

            20.3.12.2. Product Portfolio

            20.3.12.3. Sales Footprint

            20.3.12.4. Strategy Overview

        20.3.13. Bristol-Myers Squibb Company

            20.3.13.1. Overview

            20.3.13.2. Product Portfolio

            20.3.13.3. Sales Footprint

            20.3.13.4. Strategy Overview

        20.3.14. Boehringer Ingelheim International GmbH

            20.3.14.1. Overview

            20.3.14.2. Product Portfolio

            20.3.14.3. Sales Footprint

            20.3.14.4. Strategy Overview

        20.3.15. Cipla Inc.

            20.3.15.1. Overview

            20.3.15.2. Product Portfolio

            20.3.15.3. Sales Footprint

            20.3.15.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Table 1: Global High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Product Type, 2018 – 2022

Table 2: Global High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Product Type, 2023 – 2033

Table 3: Global High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2018 – 2022

Table 4: Global High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2023 – 2033

Table 5: Global High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2018 – 2022

Table 6: Global High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2023 – 2033

Table 7: Global High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2018 – 2022

Table 8: Global High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2023 – 2033

Table 9: Global High Potency Active Pharmaceutical Ingredients Market, By Region, 2018 – 2022

Table 10: Global High Potency Active Pharmaceutical Ingredients Market, By Region, 2023 – 2033

Table 11: North America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn),By Product Type, 2018 – 2022

Table 12: North America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn),By Product Type, 2023 – 2033

Table 13: North America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2018 – 2022

Table 14: North America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2023 – 2033

Table 15: North America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2018 – 2022

Table 16: North America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2023 – 2033

Table 17: North America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2018 – 2022

Table 18: North America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2023 – 2033

Table 19: North America High Potency Active Pharmaceutical Ingredients Market, By Country, 2018 – 2022

Table 20: North America High Potency Active Pharmaceutical Ingredients Market, By Country, 2023 – 2033

Table 21: Latin America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn),By Product Type, 2018 – 2022

Table 22: Latin America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn),By Product Type, 2023 – 2033

Table 23: Latin America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2018 – 2022

Table 24: Latin America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2023 – 2033

Table 25: Latin America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2018 – 2022

Table 26: Latin America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2023 – 2033

Table 27: Latin America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2018 – 2022

Table 28: Latin America High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2023 – 2033

Table 29: Latin America High Potency Active Pharmaceutical Ingredients Market, By Country, 2018 – 2022

Table 30: Latin America High Potency Active Pharmaceutical Ingredients Market, By Country, 2023 – 2033

Table 31: Europe High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn),By Product Type, 2018 – 2022

Table 32: Europe High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn),By Product Type, 2023 – 2033

Table 33: Europe High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2018 – 2022

Table 34: Europe High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2023 – 2033

Table 35: Europe High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2018 – 2022

Table 36: Europe High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2023 – 2033

Table 37: Europe High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2018 – 2022

Table 38: Europe High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2023 – 2033

Table 39: Europe High Potency Active Pharmaceutical Ingredients Market, By Country, 2018 – 2022

Table 40: Europe High Potency Active Pharmaceutical Ingredients Market, By Country, 2023 – 2033

Table 41: Asia Pacific High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Product Type, 2018 – 2022

Table 42: Asia Pacific High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Product Type, 2023 – 2033

Table 43: Asia Pacific High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2018 – 2022

Table 44: Asia Pacific High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2023 – 2033

Table 45: Asia Pacific High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2018 – 2022

Table 46: Asia Pacific High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2023 – 2033

Table 47: Asia Pacific High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2018 – 2022

Table 48: Asia Pacific High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2023 – 2033

Table 49: Asia Pacific High Potency Active Pharmaceutical Ingredients Market, By Country, 2018 – 2022

Table 50: Asia Pacific High Potency Active Pharmaceutical Ingredients Market, By Country, 2023 – 2033

Table 51: MEA High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Product Type, 2018 – 2022

Table 52: MEA High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Product Type, 2023 – 2033

Table 53: MEA High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2018 – 2022

Table 54: MEA High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Manufacturer Type, 2023 – 2033

Table 55: MEA High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2018 – 2022

Table 56: MEA High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Drug Type, 2023 – 2033

Table 57: MEA High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2018 – 2022

Table 58: MEA High Potency Active Pharmaceutical Ingredients Market Value (US$ Mn), By Application, 2023 – 2033

Table 59: MEA High Potency Active Pharmaceutical Ingredients Market, By Country, 2018 – 2022

Table 60: MEA High Potency Active Pharmaceutical Ingredients Market, By Country, 2023 – 2033